Literature DB >> 31129714

Trends in psychiatric disorders prevalence and prescription patterns of children in Alberta, Canada.

Brenda M Y Leung1, Peter Kellett2, Erik Youngson3, Josh Hathaway3, Maria Santana4.   

Abstract

PURPOSE: To describe the trends in the prevalence and incidence of children with psychiatric disorders, the types of medication prescribed, and the type of physician providing the prescriptions.
METHOD: This retrospective study linked six population-based administrative databases (2008-2015) in Alberta, Canada.
RESULTS: The prevalence of paediatric psychiatric disorders increased from 12.6 per 100 population in 2008 to 15.0 per 100 population in 2015, while the incidence rate increased from 2.0 per 100 population to 2.2 per 100 population in the same period. The proportion of patients dispensed any psychiatric medication increased from 21.4% in 2008 to 28.2% in 2015. Over the same period, dispensations for antidepressants increased from 7.0% to 11.2% and stimulants to treat ADHD, from 11.9% to 15.9%. For antidepressants, general practitioners (GPs) wrote the highest proportion of prescriptions (44.3% in 2011-48.1% in 2015), while paediatricians wrote the lowest proportion (8.7% in 2011-11.0% in 2015) and the proportion by psychiatrists decreased from 33.4% in 2011 to 27.2% in 2015. For stimulants to treat ADHD, paediatricians were the most frequent prescribers (36.9% in 2011-39.3% in 2015) followed by GPs as the second most frequent (33.1% in 2011-33.5% in 2015), while psychiatrists were the least likely to prescribe stimulants for ADHD.
CONCLUSION: The increasing trend of psychiatric diagnoses and medication prescriptions in the paediatric population is evident using population-based administrative databases. The lack of safety and adverse consequences of medication use in this cohort warrants additional monitoring data.

Entities:  

Keywords:  Disorders 3; Incidence 5; Paediatric 1; Prevalence 4; Psychiatric 2

Mesh:

Substances:

Year:  2019        PMID: 31129714     DOI: 10.1007/s00127-019-01714-w

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  22 in total

1.  Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents.

Authors:  Guilherme V Polanczyk; Giovanni A Salum; Luisa S Sugaya; Arthur Caye; Luis A Rohde
Journal:  J Child Psychol Psychiatry       Date:  2015-02-03       Impact factor: 8.982

2.  Do stimulant medications improve educational and behavioral outcomes for children with ADHD?

Authors:  Janet Currie; Mark Stabile; Lauren Jones
Journal:  J Health Econ       Date:  2014-05-16       Impact factor: 3.883

3.  Patterns of antidepressant use in Quebec children and adolescents: trends and predictors.

Authors:  Marie Tournier; Brian Greenfield; Guillaume Galbaud du Fort; Thierry Ducruet; Julie Magno Zito; Anne-Marie Cloutier; Yola Moride
Journal:  Psychiatry Res       Date:  2010-08-30       Impact factor: 3.222

Review 4.  Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents.

Authors:  Christoph U Correll; Harold E Carlson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2006-07       Impact factor: 8.829

5.  ADHD Treatment in Primary Care: Demographic Factors, Medication Trends, and Treatment Predictors.

Authors:  Tanya S Hauck; Cindy Lau; Laura Li Foa Wing; Paul Kurdyak; Karen Tu
Journal:  Can J Psychiatry       Date:  2017-01-19       Impact factor: 4.356

6.  Epidemiology of mental disorders in children and adolescents.

Authors:  Kathleen Ries Merikangas; Erin F Nakamura; Ronald C Kessler
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986

7.  Survey of atypical antipsychotic prescribing by Canadian child psychiatrists and developmental pediatricians for patients aged under 18 years.

Authors:  Tamison Doey; Kenneth Handelman; Jamie A Seabrook; Margaret Steele
Journal:  Can J Psychiatry       Date:  2007-06       Impact factor: 4.356

8.  Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.

Authors:  Andrea Cipriani; Xinyu Zhou; Cinzia Del Giovane; Sarah E Hetrick; Bin Qin; Craig Whittington; David Coghill; Yuqing Zhang; Philip Hazell; Stefan Leucht; Pim Cuijpers; Juncai Pu; David Cohen; Arun V Ravindran; Yiyun Liu; Kurt D Michael; Lining Yang; Lanxiang Liu; Peng Xie
Journal:  Lancet       Date:  2016-06-08       Impact factor: 79.321

9.  Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults.

Authors:  Laurence Y Katz; Anita L Kozyrskyj; Heather J Prior; Murray W Enns; Brian J Cox; Jitender Sareen
Journal:  CMAJ       Date:  2008-04-08       Impact factor: 8.262

10.  The impact of prescribed psychotropics on youth.

Authors:  Shaheen E Lakhan; Gareth E Hagger-Johnson
Journal:  Clin Pract Epidemiol Ment Health       Date:  2007-10-20
View more
  2 in total

Review 1.  Pharmacotherapy for Preschool Children with Attention Deficit Hyperactivity Disorder (ADHD): Current Status and Future Directions.

Authors:  Jonathan R Young; Adare Yanagihara; Rachel Dew; Scott H Kollins
Journal:  CNS Drugs       Date:  2021-03-26       Impact factor: 5.749

Review 2.  A Review of Canadian Diagnosed ADHD Prevalence and Incidence Estimates Published in the Past Decade.

Authors:  Stacey D Espinet; Gemma Graziosi; Maggie E Toplak; Jacqueline Hesson; Priyanka Minhas
Journal:  Brain Sci       Date:  2022-08-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.